Study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple Myeloma
Clinical trial NCT02626481 · COMPLETED
Trial details
- NCT number
- NCT02626481
- Sponsor
- University Hospital, Lille
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-28
- Primary completion
- 2020-03-09
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.